Prevention of infections in bone marrow transplant recipients

Infectious Disease Clinics of North America

Volumn 11, Issue 2, 1997, Pages 459-477

  Serody, J S ^a   Shea, T C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; HUMAN; INFECTION PREVENTION; INFECTIOUS COMPLICATION; MORBIDITY; MORTALITY; REVIEW; TRACHEA MUCOSA;

EID: 0030796942     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70365-2     Document Type: Article

References (72)

1. J.E. Anderson F.R. Appelbaum G. Schoch Allogeneic marrow transplantation for refractory anemia: A comparison of two preparative regimens and analysis of prognostic factors Blood 87 1996 51
2. Anonymous Prevention of bacterial infection in neutropenic patients with hematologic malignancies: A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Ann Intern Med 115 1991 7
3. Ansorg R. Heintschel von Heinegg E. P.M. Rath Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients Eur J Clin Microbiol Infect Dis 13 1994 582
4. F.R. Appelbaum L.D. Fisher E.D. Thomas Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: A five-year follow-up Blood 72 1988 179
5. G. Arlet E. Gluckman F. Gerber Measurement of bacterial and fungal air counts in two bone marrow transplant units J Hosp Infect 13 1989 63
6. K. Atkinson K. Downs M. Golenia Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: Absence of clinical cytomegalovirus infection Br J Haematol 79 1991 57
7. M. Attal D. Schlaifer H. Rubie Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: A prospective, randomized trial J Clin Oncol 9 1991 865
8. A. Bacigalupo E. Tedone Van Lint M.T. CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infections Bone Marrow Transplant 13 1994 783
9. G.P. Bodey M. Buckley Y.S. Sathe Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Ann Intern Med 64 1966 328
10. M. Boeckh R.A. Bowden J.M. Goodrich Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation Blood 80 1992 1358
11. M. Boeckh T.A. Gooley D. Myerson Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study Blood, 88 1996 4063 4071
12. M. Boeckh P.M. Woogerd T. Stevens-Ayers Factors influencing detection of quantitative cytomegalovirus antigenemia J Clin Microbiol 32 1994 832
13. R.A. Bowden S.J. Slichter M. Sayers A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant Blood 86 1995 3599
14. C.I. Bustamante J.C. Wade Herpes simplex virus infection in the immunocompromised cancer patient J Clin Oncol 9 1991 1903
15. A.W. Dekker L.F. Verdonck M. Rozenberg-Arska Infection prevention in autologous bone marrow transplantation and the role of protective isolation Bone Marrow Transplant 14 1994 89
16. F. Derouin A. Devergie P. Auber Toxoplasmosis in bone marrow-transplant recipients: Report of seven cases and review Clin Infect Dis 15 1992 267
17. H. Einsele G. Ehninger H. Hebart Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation Blood 86 1995 2815
18. D. Emanuel I. Cunningham K. Jules-Elysee Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin Ann Intern Med 109 1988 777
19. A.B. Foot Y.J. Garin P. Ribaud Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients Bone Marrow Transplant 14 1994 241
20. E. Gluckman C. Roudet I. Hirsch Prophylaxis of bacterial infections after bone marrow transplantation Chemotherapy 37 suppl 1 1991 33
21. J.L. Goodman D.J. Winston R.A. Greenfield A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation N Engl J Med 326 1992 845
22. J.M. Goodrich R.A. Bowden L. Fisher Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant Ann Intern Med 118 1993 173
23. J.M. Goodrich M. Mori C.A. Gleaves Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation N Engl J Med 325 1991 1601
24. H.F.L. Guiot W.E. Fibbe Wout J.W.V.T. Risk factor for fungal infection in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis Clin Infect Dis 18 1994 525
25. C.S. Han W. Miller R. Haake Varicella zoster infection after bone marrow transplantation: Incidence, risk factors and complications Bone Marrow Transplantation 13 1994 277
26. J.W. Hathorn Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts Hematol Oncol Clin North Am 7 1993 1051
27. B. Hertenstein W.V. Kern T. Schmeiser Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia Ann Hematol 68 1994 21
28. H.K. Holland S.P. Dix R.B. Geller Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care J Clin Oncol 14 1996 1156
29. C. Hoyle J.M. Goldman Life-threatening infections occurring more than 3 months after BMT: 18 UK Bone Marrow Transplant Teams Bone Marrow Transplant 14 1994 247
30. M.L. Landry D. Ferguson S. Cohen Effect of delayed specimen processing on cytomegalovirus antigenemia test results J Clin Microbiol 33 1995 257
31. M.A. Lew K. Kehoe J. Ritz Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: A randomized, controlled trial J Clin Oncol 13 1995 239
32. H. Link H.F. Vohringer F. Wingen Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT Bone Marrow Transplant 11 1993 403
33. G. Lucarelli C. Giardini Bone marrow transplantation in thalassemia Cancer Treat Res 76 1995 43
34. J.D. Meyers N. Flournoy E.D. Thomas Nonbacterial pneumonia after allogeneic marrow transplantation: A review of ten years' experience Rev Infect Dis 4 1982 1119
35. J.D. Meyers E.C. Reed D.H. Shepp Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation N Engl J Med 318 1988 70
36. W.J. Miller J. McCullough Balfour H.H. Jr Prevention of cytomegalovirus infection following bone marrow transplantation: A randomized trial of blood product screening Bone Marrow Transplant 7 1991 227
37. F. Momin P.H. Chandrasekar Antimicrobial prophylaxis in bone marrow transplantation Ann Intern Med 123 1995 205
38. L. Ochs X.O. Shu J. Miller Late infections after allogeneic bone marrow transplantations: Comparison of incidence in related and unrelated donor transplant recipients Blood 86 1995 3979
39. M.R. O'Donnell G.M. Schmidt B.R. Tegtmeier Predictions of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients J Clin Oncol 12 1994 827
40. A.K. Ogden C.P. Steuber Mahoney D.H. Jr Bone marrow transplantation in childhood leukemia using reverse isolation techniques Med Pediatr Oncol 18 1990 1
41. C.S. Pannuti R.D. Gingrich M.A. Pfaller Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: A 9-year study J Clin Oncol 9 1991 77
42. T.F. Patterson P. Miniter J.E. Patterson Aspergillus antigen detection in the diagnosis of invasive aspergillosis J Infect Dis 171 1995 1553
43. J.R. Perfect M.E. Klotman C.C. Gilbert Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients J Infect Dis 165 1992 891
44. F.B. Petersen C.D. Buckner R.A. Clift Infectious complications in patients undergoing marrow transplantation: A prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics Scand J Infect Dis 19 1987 559
45. F. Petersen M. Thornquist C. Buckner The effects of infection prevention regimens on early infectious complications in marrow transplant patients: A four arm randomized study Infection 16 1988 199
46. H.G. Prentice E. Gluckman R.L. Powles Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group Lancet 343 1994 749
47. E.C. Reed R.A. Bowden P.S. Dandliker Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants Ann Intern Med 109 1988 783
48. D.K. Riley A.T. Pavia P.G. Beatty The prophylactic use of low-dose amphotericin B in bone marrow transplant patients Am J Med 97 1994 509
49. C. Rotstein K.M. Cummings J. Tidings An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: A case-control study Infect Control 6 1985 347
50. S.R. Rousey S. Sussler M. Gottlieb Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation Am J Med 91 1991 484
51. H. Safah R.S. Weiner The role of bone marrow transplantation in the management of advanced local disease Surg Oncol Clin North Am 4 1995 735
52. H.G. Sayer G. Longton R. Bowden Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention Blood 84 1994 1328
53. S.C. Schimpff V.M. Young W.H. Greene Origin of infection in acute nonlymphocytic leukemia: Significance of hospital acquisition of potential pathogens Ann Intern Med 77 1972 707
54. G.M. Schmidt D.A. Horak J.C. Niland A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants: The City of Hope-Stanford-Syntex CMV Study Group N Engl J Med 324 1991 1005
55. R.J. Sheretz A. Belani B.S. Kramer Impact of air filtration on nosocomial Aspergillus infections: Unique risk of bone marrow transplant recipients Am J Med 83 1987 709
56. M.A. Slavin J.D. Meyers J.S. Remington Toxoplasma gondii infection in marrow transplant recipients: A 20 year experience Bone Marrow Transplantation 13 1994 549
57. M.A. Slavin B. Osborne R. Adams Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: A prospective, randomized, double-blind study J Infect Dis 171 1995 1545
58. P. Stiff R. Bayer M. Camarda A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: Analysis of risk factors for clinical outcome [comments] Gynecol Oncol 57 1995 278
59. R. Storb R. Etzioni C. Anasetti Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia Blood 84 1994 941
60. R. Storb R.L. Prentice C.D. Buckner Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA–identical siblings: Beneficial effect of a protective environment N Engl J Med 308 1983 302
61. J. Storek S. Ferrara N. Ku B cell reconstitution after human bone marrow transplantation: Recapitulation of ontogeny? Bone Marrow Transplant 12 1993 387
62. J. Storek A. Saxon Reconstitution of B cell immunity following bone marrow transplantation Bone Marrow Transplant 9 1992 395
63. K.M. Sullivan K.J. Kopecky J. Jocom Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation [comments] N Engl J Med 323 1990 705 712
64. J. Tollemar O. Ringden S. Andersson Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: A randomized trial in bone marrow transplant recipients Transplant Proc 25 1993 1495
65. R.L. Truitt M. Pollard Allogeneic bone marrow chimerism in germ-free mice: IV. Therapy of “Hodgkin's-like” reticulum cell sarcoma in SJL mice Transplantation 21 1976 12
66. I.Z. Tuan D. Dennison D.J. Weisdorf Pneumocystis carinii pneumonitis following bone marrow transplantation Bone Marrow Transplantation 10 1992 267
67. A.M. Vlieger G.J. Boland N.M. Jiwa Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients Bone Marrow Transplant 9 1992 247
68. E.A. Walter P.D. Greenberg M.J. Gilbert Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor [comments] N Engl J Med 333 1995 1038
69. J.R. Wingard W.G. Merz M.G. Rinaldi Increase in Candida krusei infection among patient with bone marrow transplantation and neutropenia treated prophylactically with fluconazole N Engl J Med 325 1991 1274
70. J.R. Wingard W.G. Merz M.G. Rinaldi Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients Antimicrob Agents Chemother 37 1993 1847
71. D.J. Winston W.G. Ho K. Bartoni Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients: Results of a placebo-controlled, double-blind trial Ann Intern Med 118 1993 179
72. D.J. Winston W.G. Ho C.H. Lin Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation Ann Intern Med 106 1987 12 18